Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1293.5% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 8.6 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -32.7% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | n/a | (10.61) | (16.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 1.49 | (35.79) | (43.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 2.97 | (49.63) | (78.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 3.40 | (45.60) | (55.00)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 2.29 | (33.45) | (31.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Directorate Change | 31-Oct-2024 | 15:10 | RNS |
Result of General Meeting | 31-Oct-2024 | 14:10 | RNS |
Posting of Circular & Notice of GM | 11-Oct-2024 | 16:55 | RNS |
Renalytix terminates formal sale process | 20-Aug-2024 | ShareCast |
Renalytix test gets US Medicare coverage determi... | 14-Jun-2024 | ShareCast |
Renalytix surges on takeover approach | 04-Mar-2024 | ShareCast |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
08-Oct-24 | Placing | Christopher H B Mills | 9.00p | 500,000 | £45,000.00 |
07-Oct-24 | Sell | Christopher H B Mills | 8.00p | 83,696 | £6,695.68 |
Currency | UK Pounds |
Share Price | 8.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 50.40 |
52 Week Low | 7.50 |
Volume | 632,837 |
Shares Issued | 189.93m |
Market Cap | £15.19m |
RiskGrade | 348 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:02 | 603,928 @ 8.30p |
12:34 | 1,883 @ 7.55p |
11:21 | 767 @ 7.55p |
10:03 | 25,000 @ 7.55p |
09:17 | 1,259 @ 7.94p |
You are here: research